Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc > filing NDA to Plato5
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by culateron Feb 04, 2010 4:11pm
398 Views
Post# 16753473

RE: RE: filing NDA to Plato5

RE: RE: filing NDA to Plato5Use the ignore.  He has been right so far for all the wrong reasons.   If Voclosporin gets to market and begins to generate good income the share price will shut him up.   Remember we also have to endure repeated postings like this one wasting our time responding to him.

p.s.  doubled up below .14 cents.  need 1.00 to break even.  $5.00 to retire early


culater
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities